Nextcure to present at 11th annual svb leerink global healthcare conference

Beltsville, md., feb. 08, 2022 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the 11th annual svb leerink global healthcare conference on wednesday february 16th at 10:40 am et.
NXTC Ratings Summary
NXTC Quant Ranking